Pfizer will only be able to deliver 2.9 million doses in the first few days

It is expected that Pfizer will only be able to deliver 2.9 million doses in the first few days and only up to 6.4 million doses by 19 December, according to Operation Warp Speed, the government’s vaccine effort.

“As part of the discussion on who should qualify for phase 1b access to the vaccine, ACIP has so far discussed individuals with high-risk medical conditions such as cancer, chronic kidney disease, chronic obstructive pulmonary disease (COPD), immunocompromised organ transplant status, obesity, severe heart disease, sickle cell disease, and type 2 diabetes,” said the Muscular Dystrophy Association.

For example, last month, the head of the Hawaii Healthcare Association told CNN that not a single hospital in Hawaii had a freezer that could remain cold enough to store Pfizer’s coronavirus vaccine and that the state may not have enough access to dry ice to make proper use of the company’s distribution boxes.

They resolve quickly, but CDC and other officials are worried that they might scare some people away from getting a second dose of vaccine and are preparing educational materials to let people know the symptoms are a sign that the vaccine is working to reactivate the body’s immune response and is harmless.

Vaccine counselors have already broken down priority groups into subgroups, and only the first people to receive vaccines have been identified.

Operation Warp Speed Chief Counselor Moncef Slaoui has projected that Pfizer and Moderna can make and deliver between 60 million and 70 million vaccines in January and hopes that two other vaccine makers, AstraZeneca, and Johnson & Johnson, will join the vaccine mix in the coming months.

Moderna and Pfizer each claim that they can take up to a billion doses by the end of 2021, but Moderna say that it could be half that—a product that has never been sold before—and Pfizer has already severely adjusted its timeline for delivery of vaccines after unspecified manufacturing problems.

Slaoui said that up to 15% of Pfizer and Moderna vaccine participants had quite noticeable side effects,” including nausea, body aches, headaches, and chills.

Pfizer’s vaccine had its first scare in the US with a health worker in Juneau, Alaska, suffering from an allergic reaction.

“Around one in every million people who get a vaccine can have a severe allergic reaction to the vaccine,” Dr.

And what about the essential workers? ACIP’s expert bodies, including Johns Hopkins University and the National Academies of Science, Engineering, and Medicine, suggest it will be prudent to vaccinate those who work in food processing, emergency responders, and service workers before the general public.

The US Food and Drug Administration granted emergency use authorization for Pfizer and BioNTech’s vaccine on Friday, and it is widely expected that EUA will give a similar vaccine to Moderna next week.

Reference

Trump says he is ‘not scheduled’ to take Covid-19 vaccine …. https://www.rt.com/usa/509567-trump-white-house-vaccine-later/

Resistance to Covid-19 infection remains for at least five months

Resistance to Covid-19 infection remains for at least five months, investigators reported — and probably lengthier than that.

While the study may seem perplexing and contradictory to a comparable report out of Britain this week, it is not. People’s bodies generate an army of immune substances in response to an infection, and many are complicated at first, succumbing off quickly, while others develop more gradually.

The new account out Wednesday reveals 90% of men and women who recover from #Covid-19 infections maintain a stable antibody reaction.

British study demonstrates proof of subsiding immunity to Covid-19.

Although some researchers have suggested antibodies to this virus go away rapidly, experts have found just the reverse — that more than 90% of individuals who were moderately or averagely ill produce an antibody response strong adequate to counteract the virus, and the response is preserved for countless months.
This is important for successful vaccine improvement.

Can one get infected with Covid-19 two times? It is challenging
The team examined the antibody responses of more than 30,000 people who tested positive for Covid-19 at Mount Sinai’s Health System between March and October. They characterized their antibody reactions as minimal, moderate, or high. At least 90% had moderate to high amounts, or titers, of antibodies to the virus’s surge protein — the structure it uses to grip the cells it infects.

They then accurately studied 121 individuals who restored and contributed their plasma — once three months after they first produced signs, and again five months later.
Reference
Immunity to coronavirus lingers for months, study finds. https://www.cnn.com/2020/10/29/health/covid-immunity-lingers-months-wellness/index.html

Do you believe that Fauci said: ‘We’re Nowhere Near Herd Immunity’ In The U.S.?

In a now-viral change at a U.S. Senate committee hearing Wednesday, Paul interrupted Fauci wanting to state New York City possessed a low Covid-19 illness rate as it has achieved herd resistance.Dr. Anthony Fauci elaborated on his reviews to Sen. Rand Paul Wednesday night, saying the U.S. features a “long way to go” to achieve herd resistance against Covid-19.

Photo by Anna Shvets on Pexels.com

But Fauci said Wednesday evening in a conversation using the star Alan Alda at a live-streamed Smithsonian Associates event that the U.S. is a long way from any herd resistance, which may need to have significantly more than 70% regarding the U.S. population either vaccinated against Covid-19 or infected using the virus.

“We are nowhere near herd immunity yet,” Fauci, who’s the director for the National Institute of Allergy and Infectious Diseases, told Alda during the digital occasion. “The suggestion in the united kingdom is just about two to three%.”

Fauci said herd immunity happens when a particular percentage of this population is immune or protected against infection by either vaccination or infection. Vaccines against Covid-19 being manufactured by Moderna, Pfizer, Johnson & Johnson, and AstraZeneca come in final-stage medical trials; therefore, herd immunity from vaccination is a long distance off. Americans might not get vaccines until later on in 2010 or well into 2021.

Reference:

Fauci: ‘We’re Nowhere Near Herd Immunity’ In The U.S.https://www.forbes.com/sites/brucejapsen/2020/09/23/fauci-were-nowhere-near-herd-immunityin-the-us/#4002c01a79f3

As an adult you may need one more measles vaccine

 

close up of white syringe

Photo by rawpixel.com on Pexels.com

The measles outbreak has hit people staying in 22 states, including California, where students at two Los Angeles colleges are coping with quarantines.

Now doctors are stating that if perhaps the individual was born between 1957 and 1989, the vaccination the individual had might not guarantee protection against the measles.

Dr. Daniel Lichtmann, a pediatrician with Scripps, told NBC7 most people age 62 and older are immune since they already had the measles. 1957 was the entire year when doctors in the U.S. began immunizing children with an individual measles vaccine. It was not until 1989 that doctors realized getting two shots associated with the vaccine provided a more powerful immunity.

The thing is, most adults do not have their vaccination records. For them, Lichtmann recommends they either get a blood test to check on for immunity or get another shot associated with the vaccine.